The NAB2–STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing

Cancer Genetics

Volumn 209, Issue 7-8, 2016, Pages 303-312

  Guseva, Natalya V ^a   Tanas, Munir R ^a   Stence, Aaron A ^a   Sompallae, Ramakrishna ^a,b   Schade, Jenna C ^a   Bossler, Aaron D ^a   Bellizzi, Andrew M ^a   Ma, Deqin ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

NAB2 STAT6; next generation sequencing; Solitary fibrous tumor; targeted RNA sequencing

Indexed keywords

NGFI A BINDING PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG; NAB2 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; STAT6 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FUSION GENE; GENE FUSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NAB2 STAT6 GENE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SOLITARY FIBROUS TUMOR; VERY ELDERLY; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENE PROTEINS, FUSION; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, RNA; SOLITARY FIBROUS TUMORS; STAT6 TRANSCRIPTION FACTOR;

EID: 84989822152     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2016.05.071     Document Type: Article

References (20)

1. 1 Klemperer, P., Rabin, C.B., Primary neoplasms of the pleura—a report of five cases. Arch Pathol 11 (1931), 387–414.
2. 2 Insabato, L., Siano, M., Somma, A., et al. Extrapleural solitary fibrous tumor: a clinicopathologic study of 19 cases. Int J Surg Pathol 17 (2009), 250–254.
3. 3 Nielsen, G.P., OConnell, J.X., Dickersin, G.R., et al. Solitary fibrous tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol 10 (1997), 1028–1037.
4. 4 Hasegawa, T., Matsuno, Y., Shimoda, T., et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol 30 (1999), 1464–1473.
5. 5 Morimitsu, Y., Nakajima, M., Hisaoka, M., et al. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway. APMIS 108 (2000), 617–625.
6. 6 Fletcher, C.D.M., Diagnostic Histopathology of Tumors. 2013, Elsevier Saunders, Edinburgh; New York.
7. 7 Doyle, L.A., Vivero, M., Fletcher, C.D., et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27 (2014), 390–395.
8. 8 Robinson, D.R., Wu, Y.M., Kalyana-Sundaram, S., et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45 (2013), 180–185.
9. 9 Chmielecki, J., Crago, A.M., Rosenberg, M., et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45 (2013), 131–132.
10. 10 Barthelmess, S., Geddert, H., Boltze, C., et al. Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184 (2014), 1209–1218.
11. 11 Vogels, R.J., Vlenterie, M., Versleijen-Jonkers, Y.M., et al. Solitary fibrous tumor—clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol, 9, 2014, 224.
12. 12 Svaren, J., Sevetson, B.R., Apel, E.D., et al. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 16 (1996), 3545–3553.
13. 13 Schindler, C., Darnell, J.E. Jr, Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64 (1995), 621–651.
14. 14 Zheng, Z., Liebers, M., Zhelyazkova, B., et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 20 (2014), 1479–1484.
15. 15 Demicco, E.G., Park, M.S., Araujo, D.M., et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25 (2012), 1298–1306.
16. 16 Skinner, M.E., Uzilov, A.V., Stein, L.D., et al. JBrowse: a next-generation genome browser. Genome Res 19 (2009), 1630–1638.
17. 17 Tai, H.C., Chuang, I.C., Chen, T.C., et al. NAB2-STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol 28 (2015), 1324–1335.
18. 18 Akaike, K., Kurisaki-Arakawa, A., Hara, K., et al. Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol 46 (2015), 347–356.
19. 19 Mohajeri, A., Tayebwa, J., Collin, A., et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer 52 (2013), 873–886.
20. 20 Hebenstreit, D., Wirnsberger, G., Horejs-Hoeck, J., et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17 (2006), 173–188.